UroGen Pharma Ltd. (URGN) Operating income 2016–2025
UroGen Pharma Ltd. (URGN) annual operating income history from SEC filings — each fiscal year as reported.
-$124.9MFY2025 · since FY2016: $798,000 → -$124.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$124.9M | -29.0% |
| FY2024 | -$96.8M | -47.7% |
| FY2023 | -$65.5M | +17.1% |
| FY2022 | -$79.0M | +14.4% |
| FY2021 | -$92.3M | +27.2% |
| FY2020 | -$126.7M | -15.8% |
| FY2019 | -$109.5M | -41.8% |
| FY2018 | -$77.2M | -286.9% |
| FY2017 | -$19.9M | -2600.0% |
| FY2016 | $798,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice